Home > Income Statement > SUVEN PHARMACEUTICALS

SUVEN PHARMACEUTICALS
Revenue

    Back to Income Statement
SUVEN PHARMACEUTICALS is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best 1M Momentum Mid Cap Stocks
COMMUNITY POLL
for SUVEN PHARMACEUTICALS
Please provide your vote to see the results

SUVEN PHARMACEUTICALS Last 5 Year Revenue History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Net Sales ₹1,340 Cr₹1,320 Cr₹1,010 Cr₹834 Cr₹378 Cr

What is the latest Revenue of SUVEN PHARMACEUTICALS ?

The latest Revenue ratio of SUVEN PHARMACEUTICALS is ₹1,340 Cr based on Mar2024 Consolidated results.
Year Revenue
Mar2024₹1,340 Cr
Mar2023₹1,320 Cr
Mar2022₹1,010 Cr
Mar2021₹834 Cr
Mar2020₹378 Cr

How is Revenue of SUVEN PHARMACEUTICALS Trending?

Years Revenue % Change
Mar2024 ₹1,340 Cr
1.52
Mar2023 ₹1,320 Cr
30.75
Mar2022 ₹1,010 Cr
21.10
Mar2021 ₹834 Cr
120.68
Mar2020 ₹378 Cr -

Compare Revenue of peers of SUVEN PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SUVEN PHARMACEUTICALS ₹41,399.2 Cr 5.1% 9.4% 27.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹406,267.0 Cr 0.7% 2.8% 7.9% Stock Analytics
DIVIS LABORATORIES ₹178,672.0 Cr -0.8% 3.7% 48.6% Stock Analytics
CIPLA ₹119,713.0 Cr -0.2% -0.1% -1.9% Stock Analytics
TORRENT PHARMACEUTICALS ₹119,195.0 Cr 3.4% 11.2% 17.9% Stock Analytics
DR REDDYS LABORATORIES ₹104,999.0 Cr 0.6% -5.2% -4.9% Stock Analytics


SUVEN PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
SUVEN PHARMACEUTICALS

5.1%

9.4%

27.4%

SENSEX

-0.9%

0.4%

1.4%


You may also like the below Video Courses